Authors: Gilewski, T Adluri, S Ragupathi, G Zhang, SL Yao, TJ Panageas, K Moynahan, M Houghton, A Norton, L Livingston, PO

Citation: T. Gilewski et al., Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21, CLIN CANC R, 6(5), 2000, pp. 1693-1701

Authors: Hudis, C Fornier, M Riccio, L Lebwohl, D Crown, J Gilewski, T Surbone, A Currie, V Seidman, A Reichman, B Moynahan, M Raptis, G Sklarin, N Theodoulou, M Weiselberg, L Salvaggio, R Panageas, KS Yao, TJ Norton, L

Citation: C. Hudis et al., 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study, J CL ONCOL, 17(4), 1999, pp. 1118-1126

Authors: Hudis, C Seidman, A Baselga, J Raptis, G Lebwohl, D Gilewski, T Moynahan, M Sklarin, N Fennelly, D Crown, JPA Surbone, A Uhlenhopp, M Riedel, E Yao, TJ Norton, L

Citation: C. Hudis et al., Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy, J CL ONCOL, 17(1), 1999, pp. 93-100